• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by CDK Global Inc. (Amendment)

    1/26/22 9:16:53 AM ET
    $CDK
    Retail: Computer Software & Peripheral Equipment
    Technology
    Get the next $CDK alert in real time by email
    SC 13G/A 1 us12508e1010_012622.txt us12508e1010_012622.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 8) CDK GLOBAL INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 12508E101 -------------------------------------------------------- (CUSIP Number) December 31, 2021 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 12508E101 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 20591618 (6) Shared voting power 0 (7) Sole dispositive power 21272636 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 21272636 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 18.0% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- CDK GLOBAL INC Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 1950 HASSELL ROAD HOFFMAN ESTATES IL 60169 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Address or principal business office or, if none, residence: ----------------------------------------------------------------------- BlackRock, Inc. 55 East 52nd Street New York, NY 10055 2(c) Citizenship: -------------------------------------------------------------------- See Item 4 of Cover Page 2(d) Title of class of securities: ------------------------------------------------------------------- Common Stock 2(e) CUSIP No.: See Cover Page Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: [ ] Broker or dealer registered under Section 15 of the Act; [ ] Bank as defined in Section 3(a)(6) of the Act; [ ] Insurance company as defined in Section 3(a)(19) of the Act; [ ] Investment company registered under Section 8 of the Investment Company Act of 1940; [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); [X] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; [ ] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. Amount beneficially owned: 21272636 Percent of class 18.0% Number of shares as to which such person has: Sole power to vote or to direct the vote 20591618 Shared power to vote or to direct the vote 0 Sole power to dispose or to direct the disposition of 21272636 Shared power to dispose or to direct the disposition of 0 Item 5. Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ]. Item 6. Ownership of More than 5 Percent on Behalf of Another Person If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of CDK GLOBAL INC. No one person's interest in the common stock of CDK GLOBAL INC is more than five percent of the total outstanding common shares. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. See Exhibit A Item 8. Identification and Classification of Members of the Group If a group has filed this schedule pursuant to Rule 13d-1(b)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group. Item 9. Notice of Dissolution of Group Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. Item 10. Certifications By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 26, 2022 BlackRock, Inc. Signature: Spencer Fleming ------------------------------------------- Name/Title Attorney-In-Fact The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001). Exhibit A Subsidiary BlackRock Life Limited Aperio Group, LLC BlackRock (Netherlands) B.V. BlackRock Fund Advisors* BlackRock Institutional Trust Company, National Association BlackRock Asset Management Ireland Limited BlackRock Financial Management, Inc. BlackRock Japan Co., Ltd. BlackRock Asset Management Schweiz AG BlackRock Investment Management, LLC BlackRock Advisors, LLC* BlackRock Investment Management (UK) Limited BlackRock Asset Management Canada Limited BlackRock (Luxembourg) S.A. BlackRock Investment Management (Australia) Limited BlackRock Advisors (UK) Limited BlackRock Fund Managers Ltd *Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Exhibit B POWER OF ATTORNEY The undersigned, BLACKROCK, INC., a corporation duly organized under the laws of the State of Delaware, United States (the "Company"), does hereby make, constitute and appoint each of Christopher Meade, Daniel Waltcher, Una Neary, Richard Cundiff, Charles Park, Enda McMahon, Arlene Klein, Con Tzatzakis, Karen Clark, David Maryles, Daniel Ronnen, John Stelley, Daniel Riemer, Elizabeth Kogut, Maureen Gleeson, Daniel Kalish and Spencer Fleming acting severally, as its true and lawful attorneys-in-fact, for the purpose of, from time to time, executing in its name and on its behalf, whether the Company individually or as representative of others, any and all documents, is acting certificates, instruments, statements, other filings and amendments to the foregoing (collectively, "documents") determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, Including without limitation Forms 3, 4, 5, 13D, 13F, 13G and 13H and any amendments to any of the Foregoing as may be required to be filed with the Securities and Exchange Commission, and delivering, furnishing or filing any such documents with the appropriate governmental, regulatory authority or other person, and giving and granting to each such attorney-in-fact power and authority to act in the premises as fully and to all intents and purposes as the Company might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Any such determination by an attorney-in-fact named herein shall be conclusively evidenced by such person's execution, delivery, furnishing or filing of the applicable document. This power of attorney shall expressly revoke the power of attorney dated 8th day of December, 2015 in respect of the subject matter hereof, shall be valid from the date hereof and shall remain in full force and effect until either revoked in writing by the Company, or, in respect of any attorney-in-fact named herein, until such person ceases to be an employee of the Company or one of its affiliates. IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of this 2nd day of January, 2019. BLACKROCK, INC. By:_ /s/ Daniel Waltcher Name: Daniel Waltcher Title: Deputy General Counsel
    Get the next $CDK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CDK

    DatePrice TargetRatingAnalyst
    12/16/2021$48.00Overweight → Equal-Weight
    Morgan Stanley
    8/18/2021$62.00 → $56.00Overweight
    Morgan Stanley
    More analyst ratings

    $CDK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Omnicell Elects Eileen Voynick to Board of Directors

      Sales and Operational Veteran Brings Additional Global Business Experience and Healthcare Technology Expertise to Board Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leader in transforming the pharmacy care delivery model, today announced that the Board of Directors elected Eileen Voynick to the Board, effective January 5, 2024. Ms. Voynick fills the vacancy resulting from Sara J. White, a Class I director who stepped down from the Company's Board of Directors, effective January 5, 2024. In addition, the Company announced that Vance Moore will not stand for reelection to the Company's Board at Omnicell's 2024 annual meeting of stockholders (the "2024 annual meeting") and e

      1/11/24 4:00:00 PM ET
      $MDRX
      $OMCL
      $CDK
      EDP Services
      Technology
      Computer Manufacturing
      Retail: Computer Software & Peripheral Equipment
    • BringOz Joins CDK Global Partner Program

      BringOz, the world's most complete delivery management system, today announced that it has become a participant in the CDK Global Partner Program. As a member of one of the largest third-party partner programs in the industry. BringOz is now part of a marketplace of applications and integrations that CDK Global, Inc. (NASDAQ:CDK), a leading enabler of end-to-end automotive commerce, developed to help automotive dealers succeed. "Integrating BringOz' solution with CDK's dealer management system enables automotive dealerships to simplify and streamline delivery management, save time and resources, and offer an efficient, convenient, and transparent delivery experience that today's customers

      5/11/23 7:48:00 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Dealer Pay Joins CDK Global Partner Program

      Dealer Pay, whose Point-of-Sale solutions provide modern payment acceptance to both auto and truck dealerships, today announced that it has become a participant in the CDK Global Partner Program. As a member of one of the largest third-party partner programs in the industry, DealerPay is now part of a marketplace of applications and integrations that CDK Global, Inc. (NASDAQ:CDK), a leading automotive retail technology company, developed to help automotive dealers succeed. CEO, Julie Douglas affirms, "Dealer Pay is honored to join the CDK Global Partner Program." As a vendor, Dealer Pay will provide payment solutions that streamline the sales process and improve the customer experience. De

      12/15/22 12:26:00 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology

    $CDK
    SEC Filings

    See more
    • SEC Form 15-12G filed by CDK Global Inc.

      15-12G - CDK Global, Inc. (0001609702) (Filer)

      7/18/22 9:00:24 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • CDK Global Inc. filed SEC Form 8-K: Leadership Update

      8-K - CDK Global, Inc. (0001609702) (Filer)

      7/12/22 8:38:28 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form S-8 POS filed by CDK Global Inc.

      S-8 POS - CDK Global, Inc. (0001609702) (Filer)

      7/6/22 4:42:09 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology

    $CDK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Voynick Eileen J. returned 22,827 shares to the company, closing all direct ownership in the company

      4 - CDK Global, Inc. (0001609702) (Issuer)

      7/6/22 7:31:54 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form 4: Tautges Joseph A was granted 103,073 shares and returned 231,834 shares to the company, closing all direct ownership in the company

      4 - CDK Global, Inc. (0001609702) (Issuer)

      7/6/22 7:31:28 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form 4: Shah Mahesh was granted 79,750 shares and returned 170,733 shares to the company, closing all direct ownership in the company

      4 - CDK Global, Inc. (0001609702) (Issuer)

      7/6/22 7:30:42 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology

    $CDK
    Leadership Updates

    Live Leadership Updates

    See more
    • Omnicell Elects Eileen Voynick to Board of Directors

      Sales and Operational Veteran Brings Additional Global Business Experience and Healthcare Technology Expertise to Board Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leader in transforming the pharmacy care delivery model, today announced that the Board of Directors elected Eileen Voynick to the Board, effective January 5, 2024. Ms. Voynick fills the vacancy resulting from Sara J. White, a Class I director who stepped down from the Company's Board of Directors, effective January 5, 2024. In addition, the Company announced that Vance Moore will not stand for reelection to the Company's Board at Omnicell's 2024 annual meeting of stockholders (the "2024 annual meeting") and e

      1/11/24 4:00:00 PM ET
      $MDRX
      $OMCL
      $CDK
      EDP Services
      Technology
      Computer Manufacturing
      Retail: Computer Software & Peripheral Equipment
    • AGS Health Welcomes Eileen Voynick as Board Chair

      OLYPHANT, Pa., April 8, 2021 /PRNewswire/ -- AGS Health, a leader in revenue cycle management solutions, today announced the appointment of Eileen Voynick as board chair. "I'm excited to join the AGS Health team at this pivotal time for growth," said Ms. Voynick. "I look forward to working closely with the leadership team in helping develop forward-thinking revenue cycle management strategies to achieve great results for healthcare providers, enabling them to invest further in care delivery," she noted. Eileen Voynick, AGS Health Board Chair With decades of experience in healthcare technology, life sciences and services, Ms. Voynick is an industry leader with a prove

      4/8/21 11:30:00 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology

    $CDK
    Financials

    Live finance-specific insights

    See more

    $CDK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • CDK Global Declares Regular Quarterly Cash Dividend

      HOFFMAN ESTATES, Ill., June 09, 2022 (GLOBE NEWSWIRE) -- CDK Global, Inc. (NASDAQ:CDK) has declared a regular quarterly cash dividend of $0.15 per share payable on June 29, 2022 to shareholders of record at the close of business on June 20, 2022. About CDK Global With approximately $2 billion in revenues, CDK Global (NASDAQ:CDK) is a leading provider of retail technology and software as a service (SaaS) solutions that help dealers and auto manufacturers run their businesses more efficiently, drive improved profitability and create frictionless purchasing and ownership experiences for consumers. Today, CDK serves over 15,000 retail locations in North America. For more information, visit c

      6/9/22 4:10:00 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • CDK Global, Inc. Reports Third Quarter Fiscal 2022 Results

      Revenue Growth of 6% Year over Year HOFFMAN ESTATES, Ill., May 05, 2022 (GLOBE NEWSWIRE) -- CDK Global, Inc. (NASDAQ:CDK) today announced financial results for its fiscal 2022 third quarter ended March 31, 2022. Revenue of $459.7 million in the third quarter ended March 31, 2022Revenue growth of 6% year-over-year driven by both core and acquisition related businessesStrong subscription growth due to contributions from site growth, revenue-per-site growth and the increased adoption of modern retail capability at dealershipsGAAP Diluted earnings per share of $0.56; Non-GAAP Adjusted diluted earnings per share of $0.78Adjusted EBITDA year-over-year growth of 5% and EPS growth of 13%

      5/5/22 4:10:00 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • CDK Global, Inc. Reports Second Quarter Fiscal 2022 Results

      HOFFMAN ESTATES, Ill., Feb. 03, 2022 (GLOBE NEWSWIRE) -- CDK Global, Inc. (NASDAQ:CDK) today announced financial results for its fiscal 2022 second quarter ended December 31, 2021. "We continued to see the benefit of our focus on product innovation and on customer success which resulted in another quarter of solid growth DMS sites and average revenue per site," said Brian Krzanich, CDK chief executive officer. "This growth is coming from both our core business and contributions from recent acquisitions. CDK is uniquely positioned as the center of the automotive retail ecosystem, and through our relentless focus on building connections through our SaaS solutions and investing in our vision

      2/3/22 4:10:00 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form SC 13G/A filed by CDK Global Inc. (Amendment)

      SC 13G/A - CDK Global, Inc. (0001609702) (Subject)

      8/2/22 10:17:59 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form SC 13G filed by CDK Global Inc.

      SC 13G - CDK Global, Inc. (0001609702) (Subject)

      2/11/22 2:16:52 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form SC 13G/A filed by CDK Global Inc. (Amendment)

      SC 13G/A - CDK Global, Inc. (0001609702) (Subject)

      2/11/22 11:19:53 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology

    $CDK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • CDK Global downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded CDK Global from Overweight to Equal-Weight and set a new price target of $48.00

      12/16/21 6:51:43 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Morgan Stanley reiterated coverage on CDK Global with a new price target

      Morgan Stanley reiterated coverage of CDK Global with a rating of Overweight and set a new price target of $56.00 from $62.00 previously

      8/18/21 7:37:39 AM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Oppenheimer reiterated coverage on CDK Global with a new price target

      Oppenheimer reiterated coverage of CDK Global with a rating of and set a new price target of $65.00 from $55.00 previously

      2/9/21 1:45:55 PM ET
      $CDK
      Retail: Computer Software & Peripheral Equipment
      Technology